How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care

Author:

Bachmeier Beatrice E.1ORCID,Hölzle Salome1,Gasser Mohamed1,van den Akker Marjan234ORCID

Affiliation:

1. Institute of Pharmaceutical Biology, Goethe-University, 60438 Frankfurt am Main, Germany

2. Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany

3. Department of Family Medicine, Care and Public Health Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands

4. Department of Public Health and Primary Care, Academic Centre of General Practice, KU Leuven, 3000 Leuven, Belgium

Abstract

Background: Many patients with ongoing complaints after a SARS-CoV-2 infection are treated in primary care. Existing medical guidelines on how to diagnose and treat Long-/Post-COVID are far from being comprehensive. This study aims to describe how German general practitioners (GPs) deal with this situation, what problems they experience when managing such patients, and how they solve problems associated with the diagnosis and treatment of Long-/Post-COVID. Methods and Findings: We conducted a qualitative study and interviewed 11 GPs. The most commonly described symptoms were ongoing fatigue, dyspnea, chest tightness and a decrease in physical capacity. The most common way to identify Long-/Post-COVID was by exclusion. Patients suffering from Long-/Post-COVID were generally treated by their GPs and rarely referred. A very common non-pharmacological intervention was to take a wait-and-see approach and grant sick leave. Other non-pharmacological interventions included lifestyle advices, physical exercise, acupuncture and exercises with intense aromas. Pharmacological treatments focused on symptoms, like respiratory symptoms or headaches. Our study’s main limitations are the small sample size and therefore limited generalizability of results. Conclusions: Further research is required to develop and test pharmaceutical and non-pharmaceutical interventions for patients with Long-/Post-COVID. In addition, strategies to prevent the occurrence of Long-/Post-COVID after an acute infection with SARS-CoV-2 have to be developed. The routine collection of data on the diagnosis and management of Long-/Post-COVID may help in the formulation of best practices. It is up to policymakers to facilitate the necessary implementation of effective interventions in order to limit the huge societal consequences of large groups of patients suffering from Long-/Post-COVID.

Funder

HeLaBa, Frankfurt/Main, Germany

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference25 articles.

1. Global burden of COVID-19: Situational analyis and review;Gebru;Hum. Antibodies,2021

2. Post-acute COVID-19 syndrome;Nalbandian;Nat. Med.,2021

3. Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue;Wang;Front. Public Health,2022

4. Long COVID through a Public Health Lens: An Umbrella Review;Nittas;Public Health Rev.,2022

5. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review;Chen;J. Infect Dis.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3